Thermal Ablation Approaches Similar in Efficacy for Benign Nodules Thermal Ablation Approaches Similar in Efficacy for Benign Nodules
Comparison of radiofrequency ablation, laser ablation, and high-intensity focused ultrasound showed the three approaches had similar efficacy for the treatment of benign thyroid nodules.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 18, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Comparing HIFU and Radioiodine for Toxic Thyroid Nodules Comparing HIFU and Radioiodine for Toxic Thyroid Nodules
This study compares the results between HIFU and radioiodine treatments for toxic thyroid nodules. How do they measure up?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 24, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Should Focal Therapy Be Used in Localized Prostate Cancer? Should Focal Therapy Be Used in Localized Prostate Cancer?
Should high-intensity focused ultrasound be used in men with localized prostate cancer? Dr Gerald Chodak discusses recent data on this topic.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 21, 2018 Category: Consumer Health News Tags: Urology Commentary Source Type: news

FDA approves focused US blood-brain barrier study
The U.S. Food and Drug Administration (FDA) has given clearance to researchers...Read more on AuntMinnie.comRelated Reading: MITA to promote focused ultrasound Astronauts use ultrasound to measure spinal health Acertara teams with John Hopkins on focused US study SonaCare HIFU prostate registry reaches milestone Focused Ultrasound Foundation lands $10M gift (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news

High Marks for HIFU in Early Prostate Cancer
(MedPage Today) -- Failure-free survival of almost 90% at 5 years (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 10, 2018 Category: Hematology Source Type: news

Morning Break: More Obamacare Cuts; HIFU Cheerleading; Miserable Residents
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - July 9, 2018 Category: Neurology Source Type: news

5-Year Outcomes Following A HIFU Focal Therapy Study Demonstrate Impressive Disease Control And Low Side Effect Profile For Prostate Cancer Patients In The U.K.
Sonablate® HIFU used in study to treat clinically significant nonmetastatic prostate cancer achieves complete pad-free urinary continence in 98% of men. CHARLOTTE, N.C., July 5, 2018 -- (Healthcare Sales & Marketing Network) -- SonaCare Medical, th... Devices, Oncology SonaCare Medical, HIFU , Sonablate, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 5, 2018 Category: Pharmaceuticals Source Type: news

Insightec seeks Parkinson ’ s indication in Japan for Exablate Neuro
Insightec said this week it submitted an application for pre-market approval to the Japanese Pharmaceuticals and Medical Devices Agency seeking an indication for its Exablate Neuro to treat advanced Parkinson’s Disease in patients suffering from mobility, rigidity or dyskinesia. The Israel-based company’s Exablate Neuro device uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the procedure can be performed non-invasively through an intact skull. “Insightec is committed to supporting research that extends the applications and po...
Source: Mass Device - May 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: Neurological Regulatory/Compliance Ultrasound INSIGHTEC Source Type: news

FDA issues MR thermometry warning
The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding...Read more on AuntMinnie.comRelated Reading: Philips to move MR-HIFU business to Profound Adding ultrasound boosts radiotherapy for prostate cancer More intense hyperthermia better treats cervical cancer patients MR signal, nonperfusion drive long-term success of MR-guided focused US therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 26, 2018 Category: Radiology Source Type: news

In a First, US Insurer Covers HIFU for Prostate Cancer In a First, US Insurer Covers HIFU for Prostate Cancer
Insurance coverage of the relatively new technology for salvage therapy was called ' pretty remarkable ' by a urologist who uses high-intensity focused ultrasound (HIFU).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

SonaCare HIFU prostate registry reaches milestone
High-intensity focused ultrasound (HIFU) developer SonaCare Medical said it...Read more on AuntMinnie.comRelated Reading: SonaCare highlights Medicare payment hike for HIFU SonaCare points to new Medicare HIFU reimbursement code SonaCare debuts international HIFU prostate registry New HIFU center launches in Ohio SonaCare, Invivo team up for HIFU ablation tracking (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 5, 2018 Category: Radiology Source Type: news

HIFU Doc Arrested Again, This Time for Fraud HIFU Doc Arrested Again, This Time for Fraud
This year, Ronald Wheeler, MD, is accused of scheming to defraud a man out of nearly $50,000 for a prostate cancer treatment. The man did not have prostate cancer, said another urologist.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Recent Reports About HIFU'Troubling'Recent Reports About HIFU'Troubling '
Despite new reports of HIFU for focalized therapy of prostate cancer, Dr Chodak remains unconvinced of its evidence.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 7, 2018 Category: Consumer Health News Tags: Urology Commentary Source Type: news

Insightec closes $150m Series E
Insightec said today it closed a $150 million Series E private equity round of financing with plans to use funds to support marketing, commercialization and further development of its Exablate Neuro platform. The round was led by Koch Disruptive Technologies subsidiary Koch Industries, who invested a total of $100 million during the round, the Israel-based company said. The company’s flagship Exablate Neuro device, which won FDA approval last July for treating essential tremor, uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the procedure can...
Source: Mass Device - January 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat INSIGHTEC Source Type: news

Insightec raises $150m in Series E
Insightec said yesterday it raised $150 million in a Series E round of financing led by Koch Industries’ Koch Disruptive Technologies to support its MRI-guided focused ultrasound technologies. The round was led by Koch Disruptive Technologies and joined by existing investors Elbit Imaging, York Capital, Focus Holdings, GE Healthcare (NYSE:GE), GEOC and Meditech Advisors, the Israel-based company said. “This investment aligns well with the founding principles of both Koch Disruptive Technologies and Koch Industries. With a track record of driving innovation and improving patient outcomes, Insightec has itself ...
Source: Mass Device - December 15, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News INSIGHTEC Source Type: news